Handling Imbalance Classification Virtual Screening Big Data Using Machine Learning Algorithms

Abstract

Virtual screening is the most critical process in drug discovery, and it relies on machine learning to facilitate the screening process. It enables the discovery of molecules that bind to a specific protein to form a drug. Despite its benefits, virtual screening generates enormous data and suffers from drawbacks such as high dimensions and imbalance. This paper tackles data imbalance and aims to improve virtual screening accuracy, especially for a minority dataset. For a dataset identified without considering the data’s imbalanced nature, most classification methods tend to have high predictive accuracy for the majority category. However, the accuracy was significantly poor for the minority category. The paper proposes a K-mean algorithm coupled with Synthetic Minority Oversampling Technique (SMOTE) to overcome the problem of imbalanced datasets. The proposed algorithm is named as KSMOTE. Using KSMOTE, minority data can be identified at high accuracy and can be detected at high precision. A large set of experiments were implemented on Apache Spark using numeric PaDEL and fingerprint descriptors. The proposed solution was compared to both no-sampling method and SMOTE on the same datasets. Experimental results showed that the proposed solution outperformed other methods.

A Survey Study on Proposed Solutions for Imbalanced Big Data

“…Previous studies dealing with imbalanced intrusion detection data solutions [30] and [40] used datasets from the KDD website. [41] used CMS Medicare Data, and [31] used the PubChem dataset library. While other studies devoted themselves to research dealing with a specific type of data, as in [33], the histopathological dataset was used and the fault dataset in [3] was used as classification training samples.…”

Redesigning plant specialized metabolism with supervised machine learning using publicly available reactome data

“…Furthermore, experimental data sourced from the scientific community might also be biased towards well-studied pathways or chemical classes (composition bias), which can limit the predictive scope, as well as the performance of the resultant model [52] , [51] . For example, the number of enzymatic reactions covered by the Rhea database (https://www.rhea-db.org/statistics) involving macromolecules and polymers is one and two orders of magnitude smaller than small molecule reactions, respectively.…”

Magnetic Force Classifier: A Novel Method for Big Data Classification

“…The reported results of both methods LC-KNN, and RC-KNN showed better performance when tested on Big datasets. It's also worth highlighting other Big Data classification-related studies, like as [77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,105,108,93,109,110,111,112,113,114,115,114,116,117,118,119,120,121,122,123,124,…”